Elixir Energy (ASX:EXR) Farms Out Diona Sub-block to Xstate Resources
Elixir Energy (ASX:EXR) farms out the Diona sub-block to Xstate Resources, securing operational expansions and future exploration plans.
Native Mineral Resources (ASX:NMR) Receives Second Instalment from Wes Maas to Advance Gold Production
Native Mineral Resources (ASX:NMR) secures a second $2.26M instalment from Wes Maas to advance gold production in Queensland, targeting Q3 2025 for first gold pour.
Alkane Resources Ltd (ASX:ALK) Announces March FY2025 Quarter Results
Alkane Resources (ASX:ALK) reports increased cash and bullion for March FY2025 quarter, maintaining guidance and highlighting strong operational performance.
Contact Energy (ASX:CEN) Releases March 2025 Operating Report
Contact Energy (ASX:CEN) releases its March 2025 operating report, highlighting increased netback, sales volumes, and progress on key projects.
Dropsuite Limited (ASX:DSE) Declared Unacceptable Circumstances
Dropsuite Limited (ASX:DSE) has been declared to have unacceptable circumstances by the Takeovers Panel due to major shareholder Topline’s non-compliance.
Bigtincan Holdings Limited (ASX:BTH) Shareholders Approve Acquisition Scheme
Bigtincan Holdings Limited (ASX:BTH) shareholders approve an acquisition scheme managed by a Vector Capital fund, moving towards the takeover.
Structural Monitoring Systems PLC (ASX:SMN) Updates on US Tariffs Impact
Structural Monitoring Systems PLC (ASX:SMN) announces an update on US reciprocal tariffs, confirming tariff-free status for its compliant avionics products and ongoing monitoring of trade impacts.
Russell Investments Australian Government Bond ETF (ASX:RGB) Announces Final Distribution
Russell Investments Australian Government Bond ETF (ASX:RGB) announces a final distribution of 8.8846 cents per unit, with payment on 15 April 2025.
Ansell Limited (ASX:ANN) Announces US Tariffs Update
Ansell Limited (ASX:ANN) addresses new US tariffs, maintains FY25 EPS guidance despite sourcing and pricing challenges.
Mesoblast (ASX:MSB) Announces U.S. Tariff Exemption for Allogeneic Cell Therapies
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.